Your browser doesn't support javascript.
loading
Social, cultural and economic aspects of antimicrobial resistance.
Minssen, Timo; Outterson, Kevin; Rogers Van Katwyk, Susan; Batista, Pedro Henrique D; Chandler, Clare I R; Ciabuschi, Francesco; Harbarth, Stephan; Kesselheim, Aaron S; Laxminarayan, Ramanan; Liddell, Kathleen; Osterholm, Michael T; Price, Lance; Hoffman, Steven J.
Afiliação
  • Minssen T; Center for Advanced Studies in Biomedical Innovation Law, University of Copenhagen, Copenhagen, Denmark.
  • Outterson K; Social Innovation on Drug Resistance, Boston University, Boston, United States of America (USA).
  • Rogers Van Katwyk S; Global Strategy Lab, Faculty of Health and Osgoode Law School, York University, 4700 Keele Street, Dahdaleh Building, Suite 2120, Toronto, Ontario, M3J 1P3, Canada.
  • Batista PHD; Max Planck Institute for Innovation and Competition, Munich, Germany.
  • Chandler CIR; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, England.
  • Ciabuschi F; Department of Business Studies, Uppsala University, Uppsala, Sweden.
  • Harbarth S; Antimicrobial Stewardship Program, Geneva University Hospitals, Geneva, Switzerland.
  • Kesselheim AS; Program on Regulation, Therapeutics, and Law, Harvard Medical School and Brigham and Women's Hospital, Boston University, Boston, USA.
  • Laxminarayan R; Center for Disease Dynamics, Economics & Policy, Washington, DC, USA.
  • Liddell K; Centre for Law, Medicine and Life Sciences, University of Cambridge, Cambridge, England.
  • Osterholm MT; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, USA.
  • Price L; Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
  • Hoffman SJ; Global Strategy Lab, Faculty of Health and Osgoode Law School, York University, 4700 Keele Street, Dahdaleh Building, Suite 2120, Toronto, Ontario, M3J 1P3, Canada.
Bull World Health Organ ; 98(12): 823-823A, 2020 Dec 01.
Article em En | MEDLINE | ID: mdl-33293739

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana / Antibacterianos Tipo de estudo: Health_economic_evaluation Aspecto: Determinantes_sociais_saude / Equity_inequality Limite: Humans Idioma: En Revista: Bull World Health Organ Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana / Antibacterianos Tipo de estudo: Health_economic_evaluation Aspecto: Determinantes_sociais_saude / Equity_inequality Limite: Humans Idioma: En Revista: Bull World Health Organ Ano de publicação: 2020 Tipo de documento: Article